ICUI
UBS
Global Healthcare Conference
November 13, 2024
Disclosures
ICU Medical: a Global Leader with Focus and Scale
We are a global company focused exclusively on providing IV therapy products and other core critical care products across the continuum of care
Consumables - 44%
Gravity sets, needlefree and specialty IV consumables, vascular access, sharps safety, oncology, and tracheostomy
Systems - 28%
Large volume, syringe, and ambulatory pumps; dedicated consumables; software with EHR interoperability and services
Vital Care - 28%
IV solutions, hemodynamic monitoring systems, temperature management, and respiratory care
3 1. Business unit mix percentages are based on non-GAAP revenues for the year ended December 31, 2023
ICU Medical at a Glance
2023 Revenues - $2.2 Billion
$969 M
Tracheostomy
Vascular Access
$629 M
Syringe Pumps
$615 M
Oncology
Pain Kits
Warming
Ambulatory
Anesthesia &
Respiratory
Critical Care
Infusion Therapy
LVP Infusion
IV Solutions
Consumables
Infusion Systems
Vital Care
Strong Disposables Profile
75%
10%
15%
Single-Use Consumables
Hardware
IV Solutions
Geographic Revenue Mix
68%
32%
US & Canada
OUS
Pro Forma Financial Overview
Share Price (11/8/24)
$176.79
Diluted Shares Outstanding
24.6 M
Diluted Equity Value
$4.35 Billion
Net Debt (9/30/24)
$1.30 Billion
Enterprise Value
$5.65 Billion
4
1.
2023 revenue figures, product mix and geographic mix are based on non-GAAP revenues for the year ended December 31, 2023
2.
Diluted shares outstanding and net debt figures presented in pro forma financial overview table are as of September 30, 2024
Overview - Industry and Company Landscape
Industry:
ICU Medical:
Infusion Consumables: Continuing a Legacy of Growth and Clinical Value
Established Portfolios Built on Quality, Reliability, and Clinical Performance
Infusion Therapy
﹥ Industry-leading Clave gives customers
clinically-preferred IV connector technology
﹥ Broadest catalog of IV sets allows for
standardization of care across a range
of clinical needs
﹥ Vertical integration allows for complete control
6% CAGR
Oncology
2019-20231
Positioned to Continue Stable Growth
6 1. Excludes acquired non-dedicated infusion consumables
Key Consumables Categories Stabilized and Positioned for Opportunities
Stable Foundation of Product Breadth and Clinical Value
Vascular Access
﹥ Diverse portfolio of strong brands: Jelco
,
Powerwand , Port-a-Cath , SuperCath
,
Saf-T Wing , ViaValve
﹥ Stabilized historically-challenged supply,
halting customer attrition and letting us
shift focus to share capture
Ready for Market and Portfolio Advancement
such as catheters with integrated Clave connectors
Tracheostomy
7
Infusion Systems Uniquely Positioned to Grow
2017-2023
Today
Foundation of Innovation
Bringing Meaningfully Novel
and Clinical Value
Technology to a Hungry Market
2024-Beyond
Delivering the Future of the Infusion Systems Market
"I've traveled all over the country
"You don't realize what you don't have,
and I've not used a better pump."
until you see what you can have."
- Charge Nurse, Gen. Med-Surg
- ICU Nurse
8
Strong Foundation to Build More Connected, Collaborative Care
EHR
Clinical
Interoperability
Alarm
Analytics
Forwarding
Biomedical
3rd Party
Reporting
Connectivity
Real-Time
Advanced Clinical
Location Services
LifeShield
Dashboards
IV Performance Platform
Clinician Collaboration
Secure Data Access Across Care
Pharmacists, Clinicians,
Home Care, Hospital,
Medication Safety
Alt Site, IDN
Informatics on All IV Touchpoints
Large Volume
Syringe
PainFuture
Core Value Proposition: Infusion Safety, Clinician Preference, Interoperability Leadership
9
The ICU Medical IV Performance Platform
On Market
Pipeline - New Generation of Precision IV Pumps on Single IT Platform
Large
﹥ Single channel compliment to Plum Duo
﹥ Best of breed with enhanced precision
Volume
﹥ Quietness preferred by clinicians
﹥ Best of breed "family"
Syringe
﹥ Enhanced startup time and time to
occlusion detection
﹥ Ease of use preferred in acute space
Acute
﹥ Comprehensive pain and multi-therapy
Pain
﹥ Complete IV-EHR interoperability
Home
﹥ Connectivity to home
﹥ IV-EHR Interoperability
Health
﹥ Location Services
Informatics
Single, Harmonized IT Platform Across All IV Touchpoints
Informatics, Future-Ready Foundation, Enhance Clinical Experience
10
Disclaimer
ICU Medical Inc. published this content on November 13, 2024, and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on November 14, 2024 at 02:47:08.063.